Charrois-Durand, C. et al. 2022. A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer. Canadian Urological Association Journal. 16, 6 (Jan. 2022), 199–205. DOI:https://doi.org/10.5489/cuaj.7591.